CX3CR1 and Alzheimer disease: The rescue of this receptor by carnosine could be of great relevance for future drug discovery processes in AD since it has been shown that the absence of CX3CR1 impairs the internalization of toxic tau by brain macrophages, thus favoring an accumulation of extracellular tau, a key event in the progression of AD [105].